Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-11-08 Sale |
2023-11-08 8:32 pm |
Evelo Biosciences Inc. | EVLO | Bodmer Mark CSO, President of R&D |
3,163 | $0.33 | $1,044 | 32,357 (Direct) |
View |
| 2023-11-02 Sale |
2023-11-03 4:12 pm |
Evelo Biosciences Inc. | EVLO | Bodmer Mark CSO, President of R&D |
6,854 | $0.33 | $2,262 | 47,270 (Direct) |
View |
| 2023-08-08 Sale |
2023-08-09 8:44 pm |
Evelo Biosciences Inc. | EVLO | Bodmer Mark CSO, President of R&D |
3,128 | $9.51 | $29,747 | 29,874 (Direct) |
View |
| 2023-05-23 Sale |
2023-06-12 4:01 pm |
Evelo Biosciences Inc. | EVLO | Bodmer Mark CSO, President of R&D |
22,571 | $0.1418 | $3,201 | 262,557 (Direct) |
View |
| 2023-05-08 Sale |
2023-05-10 9:31 pm |
Evelo Biosciences Inc. | EVLO | Bodmer Mark CSO, President of R&D |
68,014 | $0.1255 | $8,536 | 285,128 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-11-07 Exercise |
2023-11-08 8:32 pm |
N/A N/A |
Evelo Biosciences Inc. | EVLO | Bodmer Mark CSO, President of R&D |
6,625 | $0 | 32,357 (Direct) |
View |
| 2023-11-01 Exercise |
2023-11-03 4:12 pm |
N/A N/A |
Evelo Biosciences Inc. | EVLO | Bodmer Mark CSO, President of R&D |
12,500 | $0 | 47,270 (Direct) |
View |
| 2023-09-11 Option Award |
2023-09-13 8:55 pm |
N/A N/A |
Evelo Biosciences Inc. | EVLO | Bodmer Mark CSO, President of R&D |
37,500 | $0 | 37,500 (Direct) |
View |
| 2023-08-07 Exercise |
2023-08-09 8:44 pm |
N/A N/A |
Evelo Biosciences Inc. | EVLO | Bodmer Mark CSO, President of R&D |
6,625 | $0 | 29,874 (Direct) |
View |
| 2023-05-07 Exercise |
2023-05-09 4:08 pm |
N/A N/A |
Evelo Biosciences Inc. | EVLO | Bodmer Mark CSO, President of R&D |
132,500 | $0 | 750,642 (Direct) |
View |
| 2023-02-07 Option Award |
2023-02-09 4:32 pm |
N/A N/A |
Evelo Biosciences Inc. | EVLO | Bodmer Mark CSO, President of R&D |
530,000 | $0 | 530,000 (Direct) |
View |
| 2022-01-19 Option Award |
2022-01-21 4:50 pm |
N/A 2032-01-19 |
Evelo Biosciences Inc. | EVLO | Bodmer Mark CSO, President of R&D |
125,000 | $0 | 125,000 (Direct) |
View |
| 2021-01-27 Option Award |
2021-01-29 5:32 pm |
N/A 2031-01-27 |
Evelo Biosciences Inc. | EVLO | Bodmer Mark CSO, President of R&D |
179,000 | $0 | 179,000 (Direct) |
View |